Yoshihito Kano

9PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 15, 2026
Precision Targeting of KRAS-Mutant Cancers: Beyond G12C Toward G12D and Pan-RAS Therapeutic Strategies.

|Jan 11, 2025
Dynamic Changes in Circulating Tumor DNA During Immunotherapy for Head and Neck Cancer: SHIZUKU-HN Study.

Rika Noji, Kohki Tohyama, Shin Nakamura

|Dec 23, 2023
The Efficacy of Immunotherapy and Clinical Utility of Comprehensive Genomic Profiling in Adenoid Cystic Carcinoma of Head and Neck.

Takahiro Naito, Rika Noji, Takuma Kugimoto

|Jul 28, 2023
Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer.

Yoshihito Kano, Mitsukuni Suenaga, Hiroyuki Uetake

|Feb 11, 2023
Clinical Utility of Comprehensive Genomic Profiling in Patients with Unresectable Hepatocellular Carcinoma.

Shun Ishido, Kaoru Tsuchiya, Yoshihito Kano

|Jul 27, 2022
Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck Cancer.

Rika Noji, Kohki Tohyama, Takuma Kugimoto

Pageof 2

Frequent Collaborators

3 joint publications

Takeshi Kuroshima

2 joint publications

Masahiko Miura

2 joint publications

Yasuyuki Michi

1 joint publications

Yasuo Hamamoto